1Paul AM, Richard AR, Victoria MR, et al. Histone deacetylases and cancer: causes and therapies. Nat Rev(Cancer), 2001, 1:195-202.
2Myoung SK, Ho JK, You ML, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med, 2001, 7:437-443.
3Weidle UH, Crossmann A. Inhibition of histone deacetylase:a new strategy to target epigenetic modification for anticancer treatment. Anticancer Res, 2000, 20:1471-1479.
4Victoria MR, Todd WS, Richard AR, et al. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene associated histone acetylation.PNAS,2000, 97:10014-10019
5Patrick F, Christian K, Ubaldo S, et al. Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervix carcinoma cells circumventing human papillomavirus oncogene expression. Oncogene, 2001, 20:4768-4776.
6Kwon HI, Kim M, Kim DH. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol, 2003, 36(1):110-119.
7Pier PP. Transcription therapy for cancer. Oncogene, 2001,20:3116-3127.
8Sawa H, Murakami H, Ohshima Y, et al. Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. Brain Tumor Pathol, 2001, 18(2):109-114.
9Amin HM, Saeed S, Alkan S. Histone deacetylase inhibitots induce caspase-dependent apoptosis and downregulation of daxx in acute promyelocytic leukaemia with t (15;17).Br J Haematol, 2001, 115(2):287-297.
